News

It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
The gene therapy chief wanted to block fast-track drug approvals.
Vinay Prasad, M.D., has left the FDA less than three months into the role as director of the Center for Biologics Evaluation ...
Dr. Vinay Prasad, the controversial critic of the US Food and Drug Administration who took a top role at the regulatory ...
Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
Dr Vinay Prasad has resigned from the FDA after less than three months amid controversy over Sarepta Therapeutics' gene ...
The U.S. Food and Drug Administration's top vaccine official, Vinay Prasad, has left the agency after just three months as ...
The abrupt exit of the former CBER director raises questions about the FDA’s leadership. For now, newly appointed CDER head ...
Vinay Prasad, a US physician and researcher, rose from graduating summa cum laude at Michigan State University in philosophy ...